About
Allergy Treatments
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
15
As Collaborator
2
Total Enrollment
3,150
By Phase
PHASE3: 3PHASE1: 3NA: 2PHASE2: 6PHASE1/PHASE2: 1PHASE4: 2
By Status
COMPLETED: 16ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06920771Lead Sponsor
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
PHASE3Active, not recruiting
552 participants
Started: Sep 9, 2024 · Completed: Aug 31, 2026
NCT03758456Lead Sponsor
HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
PHASE1Completed
45 participants
Started: Nov 21, 2018 · Completed: May 17, 2019
NCT03735459Collaborator
Eczema Reminder and Accountability Program
NACompleted
21 participants
Started: Nov 13, 2018 · Completed: Jul 1, 2019
NCT03826953Collaborator
Allergy UK Research and Development Nurse Project
NACompleted
250 participants
Started: Jul 4, 2017 · Completed: Feb 28, 2021
NCT02991885Lead Sponsor
HAL-MPE1 Safety and Tolerability Study
PHASE1Completed
42 participants
Started: Dec 31, 2016 · Completed: Sep 30, 2019
Locations (1)
Headquarters
Leiden, Netherlands
Map
Loading map...